Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Korea SE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Kun Wha Pharmaceutical Co Ltd

+ Add to Watchlist

002250:KS

21,600 KRW 150 0.69%

As of 01:28:40 ET on 05/07/2015.

Company Profile for Kun Wha Pharmaceutical Co Ltd (002250)

Kun Wha Pharmaceutical Co., Ltd. is a pharmaceutical company. The Company researches, develops, manufactures, and markets drugs such as anti-inflammatory agents, antibiotics, antifungal agents, and remedies for the alimentary and cardiovascular systems.

Contact Information

Kun Wha Pharmaceutical Co Ltd

94 Garak-dong
Songpa-gu
Seoul, 138-705
Korea, Republic of (South)
Phone: 82-2-2047-7700
Fax: 82-2-443-0589

Key Executives for Kun Wha Pharmaceutical Co Ltd (002250)

Lee Joo-HyungCEO/Rep DirectorKim Dae-HwanSenior Managing Director
Lee Bok-SangSenior Managing DirectorKim Choong-RyulSenior Managing Director
Jin Seong-HoManaging DirectorPeter KyleExecutive Director
Wilhelm Robert VishwaExecutive DirectorKevin Michael BainExecutive Director
Kim Kyu-YoungExecutive Director

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil